ACB - Aurora Cannabis Inc.
After hours:
| Previous Close | 0.5360 |
| Open | 0.5251 |
| Bid | 0.0000 x 1800 |
| Ask | 0.0000 x 900 |
| Day's Range | 0.5150 - 0.5500 |
| 52 Week Range | 0.4900 - 1.9400 |
| Volume | |
| Avg. Volume | 3,400,006 |
| Market Cap | 182.543M |
| Beta (5Y Monthly) | 3.00 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.0000 |
| Earnings Date | Jun 14, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.89 |
Simply Wall St.Aurora Cannabis Inc.'s (TSE:ACB) P/S Is On The Mark
There wouldn't be many who think Aurora Cannabis Inc.'s ( TSE:ACB ) price-to-sales (or "P/S") ratio of 1.2x is worth a...
CNW GroupAurora Cannabis to Host Third Quarter and Fiscal Year 2023 Investor Conference Call and File Related Year End Information
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, announced today that it has scheduled a conference call to discuss the results for its third quarter and full fiscal year 2023 on Wednesday, June 14, 2023 at 8:15 a.m. Eastern Time | 6:15 a.m. Mountain Time. The Company will report its financial results for the third quarter and full fiscal year 2023 before the opening of markets that same day. As a reminder, Fiscal 2023
- Baystreet
Stocks in play: Aurora Cannabis Inc
Is launching a fresh lineup of innovative products, available to patients on Aurora Medical and consumers, ...
CNW GroupAurora Celebrates Summer with New Innovation Launching Across Canada
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, is launching a fresh lineup of innovative products, available to patients on Aurora Medical and consumers, at retailers across the country this summer. The company's ever-expanding portfolio includes new 1mg format, snackable edibles, premium resin vape carts with big, bold flavour, and a true-to-form signature hash. New flower products include Chemango Kush, an original strain from Occo, Aurora's estee
CNW GroupAurora and Ethypharm Reaffirm their Commitment to Promote Access to Medical Cannabis for French Patients
Aurora Europe GmbH, a subsidiary of Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), and Ethypharm are pleased to announce that they have once again been selected by the French General Directorate of Health (DGS) as exclusive suppliers of dried medical cannabis flower until the end of the French trial period. The trial has recently been extended until March 2024.
Motley FoolThe Most Likely Scenario for Aurora Cannabis Stock Doesn't Look Good
Aurora Cannabis (NASDAQ: ACB) has been struggling for years. The stock is trading down to well under $1 per share, and another reverse stock split is inevitable for the company. Aurora Cannabis' stock price fell 96% over the past three years.
The Motley Fool2 TSX Stocks to Buy This Month and 1 to Avoid
Investors looking to add quality growth stocks to their equity portfolio can consider buying Well Health right now. The post 2 TSX Stocks to Buy This Month and 1 to Avoid appeared first on The Motley Fool Canada.
Motley FoolBetter Buy: Aurora Cannabis vs. Trulieve Cannabis
One was once a favorite among cannabis investors, but the other could become the top cannabis contender.
The Motley FoolWhat’s Happening With Cannabis Stocks in May 2023?
Cannabis stocks were up this week, as the market began to turn, but how long will it last, and is more growth coming? The post What’s Happening With Cannabis Stocks in May 2023? appeared first on The Motley Fool Canada.
The Motley FoolAurora Cannabis: Time to Light Up Your Portfolio?
Here's my take on whether Aurora Cannabis (TSX:ACB) is worth adding to a growth portfolio right now, given its growth prospects and fundamentals. The post Aurora Cannabis: Time to Light Up Your Portfolio? appeared first on The Motley Fool Canada.
Motley FoolThis Troubled Stock Might Go Up in Smoke
It's been roughly five years since Canada legalized cannabis, and it's been an unpleasant ride for investors in Aurora Cannabis (NASDAQ: ACB), one of Canada's leading growers and operators. The company became a penny stock after surging to over $120 per share in 2018. While some may hope for a tremendous comeback story, sometimes a business model just isn't good.
CNW GroupAurora Expands Medical Cannabis Portfolio in Germany: New flower varieties for patients with high THC needs
Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and a leading manufacturer and supplier of dried flower for medical patients worldwide, today announced the expansion of its portfolio in Germany with the launch of two new cannabis flower products for patients. Pedanios 27/1 FRG CA and Pedanios 29/1 SRD CA are dried cannabis flower with high tetrahydrocannabinol (THC) content. With these new therapeutic options now avai
- The Motley Fool
1 Marijuana Stock I’d Buy Over Aurora Cannabis
Explore a promising marijuana stock that outshines Aurora Cannabis. Unveil the investment opportunity to boost your cannabis portfolio. The post 1 Marijuana Stock I’d Buy Over Aurora Cannabis appeared first on The Motley Fool Canada.
Motley FoolBetter Growth Stock: Aurora Cannabis vs. Tilray Brands
Marijuana stocks have fallen out of favor in the last two years. The Canadian producers Aurora Cannabis (NASDAQ: ACB) and Tilray Brands (NASDAQ: TLRY) are two of the most popular marijuana companies. Aurora Cannabis has been investors' favorite among pot stocks for a while.
CNW GroupAurora Cannabis Partners with Strainprint to Empower Patients on their Cannabis Journey
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced the launch of a new tracking program designed to support and empower cannabis patients on their wellness journey.
- Baystreet
Stocks in play: Aurora Cannabis
Today announced a fresh lineup of innovative products. Coming soon to patients at Aurora Medical and ...
CNW GroupAurora Introduces Fresh Innovation for Spring
Aurora Cannabis (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced a fresh lineup of innovative products. Coming soon to patients at Aurora Medical and to consumers at retail stores across the country, the company's expanded portfolio includes newly developed cultivars, strain-specific gummies and aromatic vapes. Flower products include two original strains from Occo, Aurora's esteemed breeding program: Pink Diesel '71 and Moon Berry.
CNW GroupAurora Repurchases ~$22 Million Principal Amount of Convertible Notes, Saving $1.2 Million in Annualized Interest Payments and Leaving ~$79 Million (US$59) of Notes Outstanding; Balance Sheet Remains Among Strongest in Canadian Cannabis Industry
Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced that it has repurchased an aggregate of approximately $22.3 million (US$16.6 million) principal amount of its convertible senior notes ("Notes") in multiple transactions since the start of April 2023 at a total cash cost, including accrued interest, of $16.7 million (US$12.4 million) and $5.3 million (US$4.0 million), including accrued interest, satisfied
Motley FoolHow Aurora Cannabis, Curaleaf, and SNDL Stack Up on 420 Day 2023
April 20th has a special significance for the cannabis industry. Three of those companies have especially attracted investors' attention in recent years -- Aurora Cannabis (NASDAQ: ACB), Curaleaf Holdings (OTC: CURLF), and SNDL (NASDAQ: SNDL) (formerly known as Sundial Growers). Aurora Cannabis is the worst of the group, with its share price plunging more than 80%.
Motley Fool3 Former High-Flying Stocks Down 92% to 99% That Billionaire Investors Can't Stop Buying
Despite losing most of their value, these former Wall Street darlings have been popular buys among billionaire money managers.
CNW GroupAurora and MedReleaf Australia Launch IndiMed Tempo 26, Further Strengthening Product Offerings for Medical Cannabis Patients
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and MedReleaf Australia today announced the launch of IndiMed Tempo 26, a range of new higher THC dried cannabis products for qualified patients under the MedReleaf Concession Scheme (MCS). Tempo 26 will add to the portfolio of products available, giving doctors the ability to prescribe from a wider range of options for medical cannabis patients.
Motley FoolWhich Canadian Cannabis Company Will Be the Next Takeover Target?
The Canadian government's decision to license over 1,000 cannabis producers, along with its inability to rein in black market operators, has been an unmitigated disaster for the country's top legal cultivators. Despite billions of dollars being spent on state-of-the-art cultivation facilities, brick-and-mortar retail outlets, and virtual storefronts, Canada's largest cannabis companies have been losing money at an alarming rate due to a vast oversupply of product in the country. In turn, profit margins have cratered across the industry, spurring some notable cannabis companies like Aurora Cannabis (NASDAQ: ACB), SNDL, and Tilray Brands to diversify into non-cannabis businesses like alcohol and vegetables in an effort to become cash-flow-positive.
- The Motley Fool
Are Cannabis Stocks a Good Buy in April 2023?
Here's why cannabis stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets for TSX investors. The post Are Cannabis Stocks a Good Buy in April 2023? appeared first on The Motley Fool Canada.
Motley FoolBetter Buy: Aurora Cannabis vs. Green Thumb Industries
Marijuana stocks have performed poorly over the last two years. Cannabis analytics firm BDSA estimates that global cannabis sales will reach $57 billion by 2026, a 13% annual growth forecast from $30 billion in 2021, with bulk of this growth expected to be driven by the Canadian and American markets. Investment opportunities seem lucrative, and investors with a higher risk appetite might stand to profit handsomely in the long run in this volatile industry.
Motley FoolWhy Aurora Cannabis Stock Is Slumping Today
Canadian marijuana company Aurora Cannabis (NASDAQ: ACB) is having another bad day. The pot seller's shares were down by a noteworthy 4.34% on moderate volume as of 2:05 p.m. ET on Monday. Since the start of the year, Aurora's stock has now shed 27.5% of its value, and the share price has fallen well below the Nasdaq's $1 bid requirement, triggering a noncompliance notice from the exchange last month.